Dissertations / Theses on the topic 'Neisseria gonorrhϾ'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 23 dissertations / theses for your research on the topic 'Neisseria gonorrhϾ.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Gbenafa-Agossa, Clémence. "Prévalence et facteurs de risque des infections génitales à Neisseria gonorrhoeae et Chlamydia trachomatis chez les travailleuses de sexe au Bénin en 2003-2004 et évaluation d'un test rapide dans le dépistage de la gonococcie génitale." Master's thesis, Université Laval, 2006. http://hdl.handle.net/20.500.11794/18455.
Full textBerglund, Torsten. "Recent trends in the epidemiology of gonorrhoea in Sweden : the role of importation and core groups /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-692-1/.
Full textROCK, JOHN PATRICK. "MOLECULAR BIOLOGY OF GONOCOCCAL DEATH FOLLOWING EXPOSURE TO THE GRANULE EXTRACTS OF HUMAN NEUTROPHILS (NEISSERIA GONORRHOEAE, PEPTIDOGLYCAN, MEMBRANE DAMAGE)." Diss., The University of Arizona, 1986. http://hdl.handle.net/10150/183844.
Full textMcMillan, Noto Jennifer. "Analysis of the mechanism of transferrin-iron acquisition by Neisseria gonorrhoeae." Online version unavailable until 9/16/2013, 2008. http://hdl.handle.net/10156/2294.
Full textHernandez, Diana Raquel. "Regulation of Expression of a Neisseria Gonorrhoeae tRNA-Modification Enzyme (Gcp)." Diss., The University of Arizona, 2012. http://hdl.handle.net/10150/242381.
Full textPerry, Elizabeth Holly. "Association of ABO, Lewis and Secretor phenotypes and genotypes with Neisseria gonorrhoeae thesis submitted in (partial) fulfilment of the Master of Applied Science, Auckland University of Technology, November 2003." Full thesis. Abstract, 2003. http://puka2.aut.ac.nz/ait/theses/PerryE.pdf.
Full textDeRocco, Amanda Jean. "Molecular Analysis of Transferrin Binding Protein B in Neisseria Gonorrhoeae." VCU Scholars Compass, 2007. http://scholarscompass.vcu.edu/etd_retro/52.
Full textPickel, Donnie. "Investigating Complement Regulator Involvement in Innate Immune Evasion by Neisseria gonorrhoeae." Ohio University / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ohiou1628181973757983.
Full textWood, Megan Lindsay Falsetta. "Coping with stress: anaerobic respiratory and oxidative stress tolerance mechanisms are critical for Neisseria gonorrhoeae biofilm formation." Diss., University of Iowa, 2009. https://ir.uiowa.edu/etd/450.
Full textBergman, Peter. "Antimicrobial peptides and pathogenic Neisseria : experimental studies in mouse, man and rat /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-428-7/.
Full textChakraborti, Srinjoy. "Therapeutic Antibody Against Neisseria gonorrhoeae Lipooligosaccharide, a Phase-variable Virulence Factor." eScholarship@UMMS, 2005. http://escholarship.umassmed.edu/gsbs_diss/905.
Full textChakraborti, Srinjoy. "Therapeutic Antibody Against Neisseria gonorrhoeae Lipooligosaccharide, a Phase-variable Virulence Factor." eScholarship@UMMS, 2017. https://escholarship.umassmed.edu/gsbs_diss/905.
Full textStrange, Heather Ruth. "Mechanism of Iron Transport Employed by Neisseria Gonorrhoeae: Contribution of Ferric Binding Protein A." VCU Scholars Compass, 2007. http://scholarscompass.vcu.edu/etd_retro/80.
Full textAbshier, Patricia Alice. "Chlamydia Trachomatis and Neisseria Gonorrhoeae: Impact of Health Literacy on Prevalence." ScholarWorks, 2015. https://scholarworks.waldenu.edu/dissertations/1769.
Full textYau, Chong-yee Miranda. "Comparison of two automated DNA amplification systems with culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in symptomatic men." Hong Kong : University of Hong Kong, 2000. http://sunzi.lib.hku.hk/hkuto/record.jsp?B23829709.
Full text邱莊儀 and Chong-yee Miranda Yau. "Comparison of two automated DNA amplification systems with culture fordetection of Chlamydia trachomatis and Neisseria gonorrhoeaeinfections in symptomatic men." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2000. http://hub.hku.hk/bib/B31969872.
Full textSimms, Amy Nicole. "Examination of Neisseria gonorrhoeae opacity protein expression during experimental murine genital tract infection /." Download the dissertation in PDF, 2005. http://www.lrc.usuhs.mil/dissertations/pdf/Simms2005.pdf.
Full textVan, Vuuren S. "Antibiotic resistance in neisseria gonorrhoeae." Thesis, 2014. http://hdl.handle.net/10210/11746.
Full textChen, Po-Lin, and 陳柏齡. "Clinical Management for Gonorrhea and Gene Analysis of Macrolide Resistance in Neisseria Gonorrhoeae." Thesis, 2008. http://ndltd.ncl.edu.tw/handle/05201985905889859130.
Full text國立成功大學
臨床醫學研究所
96
Part I. Antimicrobial Therapy and Management for Gonorrhea in an Area with High-Level Antibiotic Resistance Abstract Background The choice of antimicrobial agents for gonorrhea is an important issue of public health in an area where the prevalence of drug resistance is high. Methods During 1999 to 2004, all Neisseria gonorrhoeae isolates causing clinical gonococcal disease were collected in the National Cheng Kung University Hospital. All stored isolates were subcultured in clinical microbiology laboratory and total 65 N. gonorrhoeae isolates were available. In vitro susceptibility tests of seven antimicrobial agents for available strains by Etest strips were performed and results were demonstrated in the previous study (1). Therein, we retrospectively reviewed and analyzed antimicrobial therapy of the 65 infected persons. Results Urethritis (89%) and pelvic inflammatory diseases (42%) were the most common presentation among males and females, respectively. In average, these patients needs more than 2 courses of antimicrobial therapy, and 3 visits for index infections in outpatient clinics. Clinical surveys of other sexually-transmitted diseases (STDs) were seen in 46% of patients, and 64% were reported to public health department by doctors. All isolates were not susceptible to penicillin, and tetracycline resistance rate was nearly 100%. Among patients receiving antibiotic treatment, 6.5%, 38.8% and 37% of them had in vitro active agents in the visit 1, 2, 3 respectively. Antimicrobial agents prescribed for gonococcal infections were tetracycline (30.6%), followed by cefuroxime (16.8%) and fluoroquinolones (including ciprofloxacin, lomefloxacin, ofloxacin and levofloxacin; 15.3%). Conclusions There is a lot of space for doctors to improve antibiotic treatment and management for gonorrhea. It is crucial to develop treatment guidelines according to regional antimicrobial resistances and educational programs to improve clinical care of STDs. According to drug susceptibility test, recommended antibiotics for gonorrhea include third-generation cephalosporin and spectinomycin. Part II. Screening of erm genes and mtrR mutations in Neisseria gonorrhoeae isolates with decreased macrolide susceptibility Abstract Background In a previous study in southern Taiwan, decreased erythromycin and azithromycin susceptibilities of N. gonorrhoeae were noted. Therefore, this study was undertaken to investigate the presence of various macrolide-resistant genes and mutation in N. gonorrhoeae isolates. Materials and methods Total 48 N. gonorrhoeae isolates collected during 1999 and 2004 were available for analysis. All isolates were examined the presence of erm(B), erm(C), erm(F), mef(A) genes by PCR amplification. Mutation in mtrR region was screened with PCR amplification and sequencing. Results Of the 48 clinical isolates, 31 (64.6%) were erythromycin intermediate resistance (MIC>1 mg/L). Forty-five (93.7%) isolates had the common adenine deletion in the mtrR promoter region. Among the 45 isolates, 12 were positive for erm(B) gene and 1 positive for erm(A) gene. No isolates possessed mef(A), erm(C), and erm(F) genes. Among 17 isolates with erythromycin MIC < 1.0 mg/L, 12 had mtrR mutation, 3 had concurrent mtrR mutation and erm(B) gene, and one carried erm(B) gene only. Of the 31 isolates with erythromycin MIC > 1.0 mg/L, two had no mutation or acquired resistant genes, 20 possessed only mtrR mutation, and the other 9 had concurrent mtrR mutation and ermB gene. Isolates with mtrR mutation and erm genes did not have higher erythromycin MIC level than those with only mtrR mutation. Serotyping with monoclonal antibody plus arbitrarily-primed PCR (AP-PCR) was a powerful tool to clarify the relationship among bacterial isolates. In the present study, there was no predominate clone among the N. gonorrhoeae isolates. Conclusion High prevalence of mtrR mutations was noted in N. gonorrhoeae isolates in southern Taiwan. Treatment with azithromycin for gonococcal infection should be careful due to previous treatment failure report and potential emergence of drug resistance.
Magooa, Mahlape Precious. "Detection and molecular epidemiology of ciprofloxacin-resistant Neisseria gonorrhoeae, using a real-time polymerase chain reaction (PCR)." Thesis, 2011. http://hdl.handle.net/10539/9187.
Full textEmergence and spread of resistance to ciprofloxacin among Neisseria gonorrhoeae strains has reduced the options of effective treatment for gonococcal infections and has become a concern worldwide. Up until 2008, ciprofloxacin was recommended first-line therapy for treatment of presumptive N. gonorrhoeae infections in South Africa. At the time this MSc project was conceived, ciprofloxacin was still used as first-line therapy for presumptive gonococcal infections. A real-time polymerase chain reaction (PCR) assay was used to detect ciprofloxacin-resistant N. gonorrhoeae in DNA extracted from non-invasive urine samples collected as part of the national microbiological surveillance (NMS) programme during 2006-2007. The molecular epidemiology of ciprofloxacinresistant Neisseria gonorrhoeae was investigated by sequencing the quinolone resistance determining regions (QRDR) of the gyrA and parC genes of N. gonorrhoeae and performing N. gonorrhoeae multi-antigen sequence typing (NGMAST). As part of the NMS program for sexually transmitted infections (STIs) urine and urethral swabs were collected from men presenting with urethral discharge at primary health care clinics in Johannesburg (Gauteng), Cape Town (Western Cape) and Kimberley (Northern Cape). Urine samples and cultured N. gonorrhoeae isolates from 2006-2007 were stored at -700C and available for this study. Gonococci, previously isolated from urethral swabs, were subcultured directly onto New York City media. Isolate identity was re-confirmed by typical colony morphology and biochemical tests. Urine samples from Johannesburg were tested in order to develop the real-time PCR protocol. Subsequently, paired urethral swab DNA and N. gonorrhoeae cultures were tested from NMS patients recruited in Kimberley and Cape Town. Where possible, the PCR assay results were compared with paired antibiotic susceptibility data for ciprofloxacin. Quinolone resistance determining regions (QRDR) for gyrA and parC were screened for known point mutations associated with resistance to ciprofloxacin. Detection of mutations by the real-time PCR assay generally agreed with the phenotype of either decreased susceptibility or resistance to ciprofloxacin. All ciprofloxacin resistant gonococcal isolates had the same gyrA and parC mutations, which initially suggested that quinolone resistant N. gonorrhoeae (QRNG) in Kimberley, Cape Town and Johannesburg, may be attributed to the spread of a single clone. The use of a more discriminatory typing scheme, Neisseria gonorrhoeae Multi-Antigen Sequence Typing (NG-MAST) genotyping, revealed that ciprofloxacin resistant gonococcal isolates in Johannesburg and Cape Town were heterogeneous, with sequence type (ST) 217 being most prevalent in both cities (5/16, Johannesburg; 7/11, Cape Town). In contrast, all eight QRNG isolates from Kimberley were typed as ST 533. The use of molecular methods allowed ciprofloxacin antimicrobial susceptibility determination by PCR in non-invasive specimens. This is useful in situations where bacterial cultures are unavailable or die before antimicrobial susceptibility testing can be performed. Molecular assays to detect ciprofloxacin resistance may guide physicians as to the most ideal antimicrobial combinations for individual patient treatment. As a result of emerging widespread resistance gonococci to ciprofloxacin, in 2008, the Department of Health recommended that ciprofloxacin be removed as a first line therapy in the South African national sexually transmitted infections treatment guidelines for treatment of urethritis, cervicitis and their complications. Although ciprofloxacin is no longer used as a first-line therapy to treat gonorrhoea within our country, it may still be used in cases of severe penicillin allergy or as part of multi-drug therapy for gonococcal infections in the future. The ability to detect ciprofloxacin resistance by real-time PCR will be a useful technique in such situations.
Francis, Ian Patrick. "The characterization of novel transgenic murine models of Neisseria gonorrhoeae infection and development of a natural outer membrane vesicle anti-gonococcal vaccine candidate." Thesis, 2018. https://hdl.handle.net/2144/29993.
Full text"Epidemiologic Approaches to Understanding Gonorrhea Transmission Dynamics and the Development of Antimicrobial Resistance." Thesis, 2016. http://hdl.handle.net/10388/ETD-2016-02-2422.
Full textLin, Chia-Wei, and 林家偉. "Investigation of the antimicrobial usage for the treatment of gonorrhea and the epidemiology of antimicrobial resistance in Neisseria gonorrhoeae in Tainan, Taiwan." Thesis, 2006. http://ndltd.ncl.edu.tw/handle/22443540750765132618.
Full text國立成功大學
公共衛生研究所
94
A physician-based sentinel surveillance on Neisseria gonorrhoeae (GC) infection has identified hidden epidemic of gonorrhea in a southern Taiwan city (Tainan), where there is no standard national treatment guideline and no definite patterns of antimicrobial resistance are available currently. Therefore, we conducted a study, and the goals of this study include: (1) to determine quinolone resistance in GC positive urine specimens from the surveillance by molecular techniques; and (2) to determine the antimicrobial resistance profiles in GC isolates from a medical center in the same city. In addition, we would also identify current antimicrobial prescriptions for GC infections in Tainan. Quinolone resistance-determining region (QRDR) of gyrA and parC were amplified by PCR on 80 GC-positive urine specimens from the surveillance during November of 2003 and December of 2004 and 67 isolates were obtained from the medical center during 1999 and 2004. Then, the amplicons were sequenced directly. Sequences of QRDR were compared to published mutations associated with decreased susceptibility or resistance to fluoroquinolones in GC. Novel mutations were identified by comparing sequences in published literature and GenBank. Antimicrobial resistance profiles (penicillin, tetracycline, ofloxacin, norfloxacin, erythromycin, azithromycin, ceftriaxone, cefixime, and trimethoprim/sulphamethoxazole) of GC isolates were performed by Etest. The antimicrobial prescription for GC infections were obtained medical records of GC patients from a medical center in Tainan and from National health insurance ambulatory claim data of Feb. to Mar. 2000, Feb. to Mar. 2001 and Feb. to Mar. 2002 respectively in the same city. Overall, 90.8% (148/163) specimens had known mutations in QRDR with decreased susceptibility or resistance to fluoroquinolones. Majority (84/148) of them possessed mutations in both genes. Noticeably, two amino acid mutations were identified for the first time from two patients (gyrA:Ser91→Leu, parC:Ser87→Cys). The antimicrobial resistance profiles were available on 67 isolates, all were resistant to trimethoprim/sulphamethoxazole and Penicillin, followed by Tetracycline (97%), Fluoroquinolones (85%), and Erythromycin (20.9%). All isolates were susceptible to third-generation of Cephalosporins, Azithromycin and Spectinomycin. According to the medical records documented in the prescriptions, the top three antimicrobials for GC infection in order were Tetracycline (43.3%), Cephalosporins (24.4%), Fluoroquinolones (22.2%). We can also found a similar result if we combined the antimicrobial prescriptions from medical center, regional & district hospitals in the NHI database. Differently, the most use of antimicrobial for GC was Cephalosporins (36.8%) in clinics from the database of National Health Insurance. High mutation rates in QRDR coupling with low susceptibility rates to commonly used prescribed antimicrobials for treatment of gonorrhea in this southern Taiwan city indicate that an urgent need for a national treatment guideline and an effective molecular epidemiologic surveillance on GC infection and resistance patterns is warranty before the hidden epidemic becomes out of control.